FIELD: veterinary medicine.
SUBSTANCE: invention relates to a compound selected from (S)-7-Methyl-2-(2-methyl-1,4-dioxa-8-azaspiro[4.5]decane-8-yl)-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazine-4-one, (S)-5-Methyl-2-(2-methyl-1,4-dioxa-8-azaspiro[4.5]decane-8-yl)-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazine-4-one and 2-(4-(Cyclohexylmethyl)piperazine-1-yl)-5-methyl-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazine-4-one, which has activity against Mycobacterium tuberculosis H37Rv and (PDR) 12700, M. Marinum, M. Vaccae 10670 strains, pharmaceutical compositions based on them and their use for the therapeutic or preventive treatment of mycobacterial infection in mammals.
EFFECT: obtaining compounds for treatment of mammalian infections.
4 cl, 4 dwg, 1 tbl, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL BENZOTHIAZINONE DERIVATIVES AND USE THEREOF AS ANTIBACTERIAL AGENTS | 2006 |
|
RU2395508C1 |
| NEW SALICYLIC ACID DERIVATIVES, THEIR PHARMACEUTICALLY ACCEPTABLE SALT, COMPOSITIONS AND METHOD FOR APPLICATION | 2013 |
|
RU2641903C2 |
| OXADIAZOLES AS MUSCARINIC RECEPTOR AGONISTS M AND/OR M | 2019 |
|
RU2817018C2 |
| DERIVATIVES OF ANDROSTANE SUBSTITUTED AT 16-POSITION WITH QUATERNARY AMMONIUM GROUP, PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2124021C1 |
| DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE | 2014 |
|
RU2662832C2 |
| 1,1,1-TRIFLUORO-3-HYDROXYPROPANE-2-YLCARBAMATE DERIVATIVES AS MAGL INHIBITORS | 2018 |
|
RU2720203C1 |
| AZASPIRO DERIVATIVES AS TRPM8 ANTAGONISTS | 2015 |
|
RU2683309C2 |
| BICYCLIC HETEROCYCLIC SPIROCOMPOUNDS | 2010 |
|
RU2506266C2 |
| PYRAZOLOTRIAZINE DERIVATIVES AS SELECTIVE INHIBITORS OF CYCLIN-DEPENDENT KINASES | 2013 |
|
RU2645347C2 |
| CYCLIC CYANOENONE DERIVATIVES AS KEAP1 MODULATORS | 2021 |
|
RU2822828C1 |
